Robert A. Durham
Affiliations: | Pfizer, Inc., San Diego, CA, United States |
Area:
Alzheimer's, drug discoveryGoogle:
"Robert Durham"Mean distance: 17.6 (cluster 19) | S | N | B | C | P |
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wood KM, McCush F, Conboy JJ, et al. (2010) IP/MS analysis of human CSF Aβ following a single dose of the C-terminal anti-Aβ antibody ponezumab (PF-04360365) to Alzheimer patients Alzheimers & Dementia. 6 |
Wang EQ, Wentland J, Rajadhyaksha M, et al. (2009) P3-273: Pharmacokinetic and pharmacodynamic evaluation of PF-04360365, a humanized monoclonal anti-amyloid antibody, in young and aged cynomolgus monkeys Alzheimer's & Dementia. 5: P423-P423 |
Conboy JJ, Wood KG, Lame ME, et al. (2008) Modification of amyloid-beta(1-40) by a protease inhibitor creates risk of error in mass spectrometric quantitation of amyloid-beta(1-42). Analytical Biochemistry. 382: 147-9 |
Beach TG, Walker DG, Potter PE, et al. (2005) Cortical cholinergic deafferentation induces aβ deposition toward a physiological animal model of alzheimer's disease Molecular Neurosurgery With Targeted Toxins. 143-180 |
Sunderland T, Mirza N, Putnam KT, et al. (2004) Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biological Psychiatry. 56: 670-6 |
Cataldo AM, Petanceska S, Terio NB, et al. (2004) Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiology of Aging. 25: 1263-72 |
Beach TG, Walker DG, Sue LI, et al. (2003) Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes Aβ Deposition: Towards a Physiologic Animal Model of Alzheimers Disease Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents. 3: 57-75 |
Walker LC, Bian F, Callahan MJ, et al. (2002) Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Amino Acids. 23: 87-93 |
Walker LC, Callahan MJ, Bian F, et al. (2002) Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides. 23: 1241-7 |
Gyure KA, Durham R, Stewart WF, et al. (2001) Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Archives of Pathology & Laboratory Medicine. 125: 489-92 |